Display Settings:

Format

Send to:

Choose Destination

    Ann Intern Med. 2004 Jul 20;141(2):118-25.

    A three-part intervention to change the use of hormone replacement therapy in response to new evidence.

    Roumie CL, Grogan EL, Falbe W, Awad J, Speroff T, Dittus RS, Elasy TA.

    Veterans Administration Tennessee Valley Healthcare System and Vanderbilt University, Nashville, Tennessee, USA. christianne.roumie@vanderbilt.edu

    Comment in:

    BACKGROUND: Slow adaptation of new information by providers may result in suboptimal care. OBJECTIVE: To evaluate changes in prescriptions for combination hormone replacement therapy (HRT) after a multicomponent intervention to deliver new information to patients and providers. DESIGN: Quasi-experimental study with multiple baselines. SETTING: Veterans Affairs Tennessee Valley Healthcare System (VA-TVHS). PATIENTS: Female veterans age 50 to 79 years who had a prescription filled at the VA-TVHS for combination HRT between 1 January 2002 and 1 July 2002. MEASUREMENTS: Discontinuation of HRT. INTERVENTION: A 3-part intervention consisted of 1) notifying patients who were using combination HRT of the results of the Women's Health Initiative study (patient education component), 2) sending all providers an e-mail with the Women's Health Initiative study results (provider education component), and 3) placing an electronic alert in each eligible patient's chart (provider care component). The alert asked providers to reevaluate the need for combination HRT. The intervention was implemented at different VA-TVHS sites in a stepwise fashion to differentiate intervention effect from media effect. Study follow-up continued through 31 December 2002. RESULTS: The total rate of discontinuation of combination HRT was 70.3% in 2002. The proportion of discontinuation from time of media release until intervention was 23.3%. After initiation of the intervention, an additional 43% of the original cohort discontinued use of HRT; this percentage represents a 59% relative decrease in HRT use among patients. After adjustment for time, the discontinuation rate per day was 4.9 times higher after the multifacted intervention than after the media release (95% CI, 1.8 to 13.1). LIMITATIONS: A true control group is lacking. CONCLUSION: A multifaceted approach in an integrated health care system with standardized methods of communication is an effective way to implement patient-centered, effective, and timely care with changing medical knowledge.

    PMID: 15262667 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Estrogen (Cenestin®, Enjuvia®, Estrace®, ...)

      Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estrogen...